The diagnosis and management of Cushing's syndrome in pregnancy
Endogenous Cushing's syndrome (CS) is rarely encountered during pregnancy. Clinical and
biochemical changes in healthy pregnancy overlap with those seen in pregnancy …
biochemical changes in healthy pregnancy overlap with those seen in pregnancy …
[HTML][HTML] Cushing's disease: adrenal steroidogenesis inhibitors
R Pivonello, C Simeoli, N Di Paola, A Colao - Pituitary, 2022 - Springer
Abstract Cushing's disease (CD), caused by an adrenocorticotropic hormone (ACTH)-
secreting pituitary tumor, is the most common form of Cushing's syndrome (CS), accounting …
secreting pituitary tumor, is the most common form of Cushing's syndrome (CS), accounting …
Sex differences in offspring risk and resilience following 11β-hydroxylase antagonism in a rodent model of maternal immune activation
J Martz, MA Shelton, L Geist, ML Seney… - …, 2024 - nature.com
Maternal immune activation (MIA) puts offspring at greater risk for neurodevelopmental
disorders associated with impaired social behavior. While it is known that immune signaling …
disorders associated with impaired social behavior. While it is known that immune signaling …
Approach to the patient treated with steroidogenesis inhibitors
F Castinetti, LK Nieman, M Reincke… - The Journal of …, 2021 - academic.oup.com
Steroidogenesis inhibitors can be given to control the hypercortisolism of Cushing's
syndrome in various situations: when surgery has been unsuccessful or not possible; in …
syndrome in various situations: when surgery has been unsuccessful or not possible; in …
Updates in adrenal steroidogenesis inhibitors for Cushing's syndrome–a practical guide
EV Varlamov, AJ Han, M Fleseriu - Best Practice & Research Clinical …, 2021 - Elsevier
Medical therapy is essential in the management of patients with Cushing's syndrome (CS)
when curative surgery has failed, surgery is not feasible, when awaiting radiation effect, and …
when curative surgery has failed, surgery is not feasible, when awaiting radiation effect, and …
Conundrums of Diagnosis and Management of Cushing's Syndrome in Pregnancy
ML Gheorghiu, M Fleseriu - Endocrinology and Metabolism …, 2024 - endo.theclinics.com
Endogenous Cushing's syndrome (CS) is a rare disease, with an estimated global, general
population incidence of approximately 2 to 4.5 per million per year. 1, 2 Although most …
population incidence of approximately 2 to 4.5 per million per year. 1, 2 Although most …
An evaluation of pharmacological options for Cushing's disease: what are the state-of-the-art options?
M Martino, N Aboud, B Lucchetti, G Salvio… - Expert Opinion on …, 2023 - Taylor & Francis
ABSTRACT Introduction Untreated Cushing's syndrome (CS) is associated with significant
morbidity and mortality. Cortisol normalization is a key goal to treatment. Pituitary surgery …
morbidity and mortality. Cortisol normalization is a key goal to treatment. Pituitary surgery …
库欣综合征的诊疗进展
刘岑， 赵紫楠， 陈頔， 胡欣 - 罕见病研究, 2024 - jrd.chard.org.cn
库欣综合征(CS) 是一种由肾上腺皮质分泌过多糖皮质激素引起的内分泌疾病,
其诊断与治疗均具挑战性. 诊断过程需结合实验室和影像学检查, 进行筛查, 定性及定位 …
其诊断与治疗均具挑战性. 诊断过程需结合实验室和影像学检查, 进行筛查, 定性及定位 …
Endocrine hypertension in pregnancy
F Jebasingh, N Thomas - Endocrine Hypertension, 2023 - Elsevier
Pregnancy is a state wherein there are several physiological hormonal changes. Moreover,
hypertension is common during pregnancy. A number of hormonal alterations could induce …
hypertension is common during pregnancy. A number of hormonal alterations could induce …
[HTML][HTML] Cushing disease treated successfully with metyrapone during pregnancy
IR Bass, A Leiter, Y Pozharny, R Shrivastava… - AACE Clinical Case …, 2022 - Elsevier
Background Cushing disease (CD) during pregnancy is a rare but serious disease that
adversely impacts maternal and fetal outcomes. As the sole use of metyrapone in the …
adversely impacts maternal and fetal outcomes. As the sole use of metyrapone in the …